 Mohd Minhajuddin
Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intercellular Adhesion Molecule-1 | 7 | 2009 | 154 | 0.820 |
Why?
| | Thrombin | 7 | 2009 | 139 | 0.540 |
Why?
| | NF-kappa B | 5 | 2008 | 641 | 0.500 |
Why?
| | Azacitidine | 3 | 2024 | 129 | 0.440 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 534 | 0.400 |
Why?
| | Endothelial Cells | 4 | 2009 | 687 | 0.370 |
Why?
| | Protein Kinase C-delta | 2 | 2008 | 70 | 0.370 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 41 | 0.320 |
Why?
| | Transcription Factor RelA | 5 | 2009 | 82 | 0.300 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2024 | 172 | 0.300 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 329 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 398 | 0.270 |
Why?
| | Neoplasm, Residual | 2 | 2024 | 104 | 0.270 |
Why?
| | Sulfonamides | 3 | 2024 | 445 | 0.260 |
Why?
| | Endothelium, Vascular | 3 | 2006 | 847 | 0.240 |
Why?
| | Carrier Proteins | 1 | 2008 | 695 | 0.240 |
Why?
| | Protein Kinases | 1 | 2005 | 307 | 0.210 |
Why?
| | Gene Expression Regulation | 3 | 2008 | 2320 | 0.190 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 785 | 0.180 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 1355 | 0.180 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 212 | 0.170 |
Why?
| | Cell Nucleus | 3 | 2009 | 554 | 0.170 |
Why?
| | Phosphorylation | 5 | 2009 | 1569 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 520 | 0.140 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2008 | 360 | 0.120 |
Why?
| | Benzofurans | 1 | 2014 | 18 | 0.110 |
Why?
| | Triterpenes | 1 | 2014 | 17 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2008 | 395 | 0.110 |
Why?
| | Mutation | 1 | 2024 | 3346 | 0.110 |
Why?
| | NF-KappaB Inhibitor alpha | 3 | 2009 | 52 | 0.100 |
Why?
| | I-kappa B Proteins | 3 | 2009 | 79 | 0.100 |
Why?
| | Leukemia | 1 | 2014 | 209 | 0.100 |
Why?
| | Cell Line | 2 | 2008 | 2637 | 0.090 |
Why?
| | Phosphotyrosine | 2 | 2008 | 33 | 0.090 |
Why?
| | Hemostatics | 2 | 2008 | 47 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 329 | 0.090 |
Why?
| | Cofilin 1 | 1 | 2009 | 5 | 0.080 |
Why?
| | Sirolimus | 2 | 2014 | 181 | 0.080 |
Why?
| | I-kappa B Kinase | 2 | 2008 | 50 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2008 | 36 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 213 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2008 | 785 | 0.070 |
Why?
| | Signal Transduction | 3 | 2008 | 4515 | 0.070 |
Why?
| | Cytoskeleton | 1 | 2006 | 176 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 388 | 0.060 |
Why?
| | Actins | 1 | 2006 | 381 | 0.060 |
Why?
| | Drug Synergism | 1 | 2005 | 316 | 0.060 |
Why?
| | Fibroblasts | 1 | 2008 | 838 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2004 | 227 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 260 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1879 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2006 | 608 | 0.050 |
Why?
| | Down-Regulation | 1 | 2005 | 594 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2008 | 2570 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2024 | 12554 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2024 | 6347 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 56 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 993 | 0.050 |
Why?
| | Humans | 11 | 2024 | 114696 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 2022 | 620 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 935 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1314 | 0.040 |
Why?
| | Adult | 3 | 2024 | 30552 | 0.040 |
Why?
| | Mice | 2 | 2014 | 14871 | 0.040 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2008 | 110 | 0.030 |
Why?
| | Prognosis | 1 | 2024 | 3329 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 2 | 2009 | 399 | 0.030 |
Why?
| | DNA | 3 | 2008 | 1352 | 0.030 |
Why?
| | Aged | 2 | 2024 | 19074 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2008 | 3886 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2006 | 2553 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2014 | 89 | 0.030 |
Why?
| | Middle Aged | 2 | 2024 | 26737 | 0.030 |
Why?
| | Animals | 2 | 2014 | 31708 | 0.020 |
Why?
| | Protein Binding | 2 | 2008 | 1890 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 698 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 531 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 493 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 9088 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 445 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 546 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 16 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 73 | 0.020 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 80 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1141 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 747 | 0.020 |
Why?
| | Syk Kinase | 1 | 2008 | 18 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 301 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 395 | 0.020 |
Why?
| | Male | 2 | 2024 | 55604 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1518 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 433 | 0.020 |
Why?
| | Female | 2 | 2024 | 59518 | 0.020 |
Why?
| | Phosphoserine | 1 | 2006 | 33 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10471 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 2796 | 0.020 |
Why?
| | Dimerization | 1 | 2006 | 176 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2008 | 337 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2006 | 88 | 0.020 |
Why?
| | RNA Stability | 1 | 2006 | 90 | 0.020 |
Why?
| | Apoptosis | 1 | 2014 | 2363 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1131 | 0.010 |
Why?
| | Umbilical Veins | 1 | 2004 | 58 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2006 | 477 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 432 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1621 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1140 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1176 | 0.010 |
Why?
|
|
Minhajuddin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|